1983-1990 Undergraduate studies in biochemistry, University of Vienna, Austria. Diploma thesis carried out at the Research Institute of Molecular
Pathology, Vienna, Austria.
1991-1994 PhD in biochemistry, University of Vienna, Austria. Thesis carried out at the Research Institute of Molecular Pathology, Vienna, Austria.
1994-1997 Postdoctoral fellow. University of California, School of Pharmacy. Erwin Schrödinger and Max Kade fellowships.
Since 1997 Technische Universität München, Institute of Experimental Oncology
and Therapy Research (since 2013 Institute of Molecular Immunology
– Experimental Oncology). Staff Scientist, group leader.
2003 Cofounder of OZ Biosciences SAS, Marseille, France.
2003-2004 Habilitation Thesis at Technische Universität München, Medical
Faculty.
Since 2009 Co-founder and managing director of Ethris GmbH, Martinsried,
Germany.
1994 Austrian Academy of Sciences. Erwin Schrödinger Fellowship.
1996 Max Kade Foundation, New York and Austrian Academy of Sciences.
Max Kade Fellowship
1998 Young Researchers’ Award of the Federal Country of Upper Austria.
2001 Best of Biotech Business Plan Competition, Vienna. Award for one of
the ten best business plans
2002 Award of the Work Group Biomaterials of the German Surgical Society.
Since 2006 Member of the German Cluster of Excellence “Nanosystems Initiative Munich (NIM)” and of Center of Nanoscience (CeNS) Munich
2006-2009 Coordinator of the EU-funded project “Magselectofection”
2008 Munich Business Plan Competition and Science4Life Venture Cup. Award for one of the ten best business plans.
Since 2009 Deputy coordinator of the DFG Research Unit “Nanoparticle-based targeting of gene- and cell-based therapies” (Nanoguide/FOR 917).
2011 Go-Bio grant of the Federal Ministry of Education and Research together with Dr. Carsten Rudolph.
